BioHealth News

Career Opportunity with BHI: Life Sciences Business Strategist

Career Opportunity with BHI: Life Sciences Business Strategist

Read More
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock

CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock

Read More
CityBiz+ – Biosim AI

CityBiz+ – Biosim AI

Read More
Amarex Celebrates Its 25th Anniversary

Amarex Celebrates Its 25th Anniversary

Read More
I-Mab Signs Agreement to Divest its Assets and Business Operations in China to Become Rockville-Based Biotech

I-Mab Signs Agreement to Divest its Assets and Business Operations in China to Become Rockville-Based Biotech

Read More
BHI Remembers Dr. William G. Hearl: A Pillar of the BioHealth Capital Region

BHI Remembers Dr. William G. Hearl: A Pillar of the BioHealth Capital Region

Read More
BullFrog AI Announces Closing Of $5.7M Public Offering

BullFrog AI Announces Closing Of $5.7M Public Offering

Read More
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Read More
Children’s National Event: Navigating from Research to Market Approval: The AGAMREE Journey

Children’s National Event: Navigating from Research to Market Approval: The AGAMREE Journey

Read More
BISNOW: In Nation’s Tightest Life Sciences Market, There Is Little Appetite To Build More Space

BISNOW: In Nation’s Tightest Life Sciences Market, There Is Little Appetite To Build More Space

Read More
Baltimore Banner: One biotech company is leaving, one is staying. What does that say about Baltimore?

Baltimore Banner: One biotech company is leaving, one is staying. What does that say about Baltimore?

Read More
WBJ: AstraZeneca doubles down on Montgomery County with $300M investment

WBJ: AstraZeneca doubles down on Montgomery County with $300M investment

Read More
GEN: Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B

GEN: Novo Holdings Buys Catalent for $16.5B; Sells Three Sites to Novo Nordisk for $11B

Read More
J.P. Morgan Releases 2024 Innovation Economy Outlook: What’s Next for Venture Capital?

J.P. Morgan Releases 2024 Innovation Economy Outlook: What’s Next for Venture Capital?

Read More
BioHealth Innovation, Inc. (BHI) Welcomes Yaminah Leggett-Wells, Senior Director, Alliance Management at Amgen as Newest Member of the Board of Directors

BioHealth Innovation, Inc. (BHI) Welcomes Yaminah Leggett-Wells, Senior Director, Alliance Management at Amgen as Newest Member of the Board of Directors

Read More